TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 2 | -2 | -6 | -2 | -39 | -44 | -24 | -19 |
| S | %wins | 100 | 100 | 50 | 100 | 100 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/11 18:10 | 5/26/11 | DNDN | Dendreon Corp | DE | Health | Drug | Pharmaceutical Preparations | Ranieri Richard J | WA | O | SVP,HR | S | -261 | 41.00 | 33 | -6 | -10 | 57 | D | 87 | -2 | 17 | 26 | 0 | 7 | 10 | 7 | -3 | -6 | -5 | -72 | -82 | |
2/14/08 17:23 | 2/12/08 | NBIX | Neurocrine Biosciences Inc | CA | Health | BioPrd | Biological Products, (No Diag | Ranieri Richard J | CA | O | SVP,HR | S | -49 | 5.02 | 3 | -10 | -50 | 10 | D | -92 | -61 | -51 | -49 | 12 | -7 | -6 | -1 | -1 | -6 | 2 | -6 | -5 | -24 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |